Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX12 | P18054 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | ALPL | P05186 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24347533 | 0.83 | ALOX12 (0.52) | ALOX12HPGDALDH1A1GAAMAPT | |
| SCHEMBL14065008 | 0.81 | ALOX12 (0.60) | ALOX12HPGDALDH1A1GAAMAPT | |
| SCHEMBL3343137 | 0.81 | ALOX12 (0.67) | ALOX12HPGDALDH1A1GAAMAPT | |
| SCHEMBL5184971 | 0.81 | ALOX12 (0.60) | ALOX12HPGDALDH1A1GAAMAPT | |
| SCHEMBL13369666 | 0.80 | SMN1; SMN2 (0.53) | HPGDALDH1A1GAAMAPTKMT2A | |
| SCHEMBL20924880 | 0.80 | POLB (0.46) | ALOX12HPGDALDH1A1GAAMAPT | |
| SCHEMBL183463 | 0.79 | ALDH1A1 (0.59) | HPGDALDH1A1GAAMAPTKMT2A | |
| SCHEMBL1403667 | 0.79 | ALOX12 (0.58) | ALOX12HPGDALDH1A1GAAMAPT | |
| SCHEMBL6307134 | 0.78 | NPC1 (0.59) | HPGDALDH1A1GAAMAPTKMT2A | |
| SCHEMBL21507878 | 0.78 | KMT2A (0.40) | ALOX12HPGDALDH1A1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3901131-A1 | METHOD FOR PRODUCING AMINE THROUGH REDUCTION OF AMIDE | Takasago International Corporation (JP) | 2021-10-27 | — | — | EP | disclosed |
| EP-3611176-B1 | NITROGEN-CONTAINING CYCLIC COMPOUND AND COLOR-CHANGING FILM COMPRISING SAME | LG CHEMICAL LTD (KR) | 2021-06-02 | — | — | EP | disclosed |
| EP-3782986-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2021-02-24 | — | — | EP | disclosed |
| EP-3192848-B1 | ORGANIC LIGHT EMITTING DIODE | LG CHEMICAL LTD (KR) | 2020-08-12 | — | — | EP | disclosed |
| EP-3693362-A1 | PARASITIC PLANT GERMINATION REGULATOR | National University Corporation Nagoya University (JP) | 2020-08-12 | — | — | EP | disclosed |
| EP-2427451-B1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM BIOLAB CO LTD (JP) | 2019-03-20 | — | — | EP | disclosed |
| EP-2887943-B1 | NOVEL 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES | VIROSTATICS SRL (IT) | 2017-12-06 | — | — | EP | disclosed |
| EP-3192848-A1 | ORGANIC LIGHT EMITTING DIODE | LG Chem, Ltd. (KR) | 2017-07-19 | — | — | EP | disclosed |
| EP-3124519-A1 | COPOLYMER AND ORGANIC SOLAR CELL COMPRISING SAME | LG Chem, Ltd. (KR) | 2017-02-01 | — | — | EP | disclosed |
| US-9416080-B2 | Catalytic C—H bond activation | GEORGETOWN UNIVERSITY (US) | 2016-08-16 | — | — | US | disclosed |
| EP-2439202-B1 | INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 | SALVAT LAB SA (ES) | 2016-04-20 | — | — | EP | disclosed |
| US-20150321982-A1 | Catalytic C-H Bond Activation | NATIONAL SCIENCE FOUNDATION | 2015-11-12 | — | — | US | disclosed |
| EP-1575940-B1 | 2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER | NOVARTIS AG (CH) | 2011-10-05 | — | — | EP | disclosed |
| EP-1105413-B1 | HEPATITIS C INHIBITOR TRI-PEPTIDES | BOEHRINGER INGELHEIM CA LTD (CA) | 2009-04-29 | — | — | EP | disclosed |
| WO-2008112156-A1 | CHEMOKINE RECEPTOR MODULATORS | ALTIRIS THERAPEUTICS (US) | 2008-09-18 | — | — | WO | disclosed |
| WO-2008045535-A2 | CONVERTIBLE NUCLEOSIDE DERIVATIVES | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2008-04-17 | — | — | WO | disclosed |
| WO-2005030725-A1 | DERIVATIVES OF 3-AMINOCARBONYLQUINOLINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES AND INTERMEDIATES FOR THEIR PREPARATION | GLAXO GROUP LIMITED (GB) | 2005-04-07 | — | — | WO | disclosed |
| EP-0736037-A1 | NOVEL INTERMEDIATES FOR THE SYNTHESIS OF L-ASPARTYL-D-$g(a)-AMINOALKANOYL-(S)-N-$g(a)-ALKYLBENZYL AMIDES USEFUL AS ARTIFICIAL SWEETENERS | THE COCA-COLA COMPANY (US) | 1996-10-09 | — | — | EP | disclosed |
| EP-0127802-B1 | META- AND PARA-ISOPROPENYL-ALPHA,ALPHA-DIMETHYLBENZYLAMINE | AMERICAN CYANAMID COMPANY (US) | 1988-04-20 | — | — | EP | disclosed |
| EP-0127802-A2 | Meta- and para-isopropenyl-alpha,alpha-dimethylbenzylamine | AMERICAN CYANAMID COMPANY (US) | 1984-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150321982-A1 | Catalytic C-H Bond Activation | CBR3, CBR1, SOD3 | ALOX12 1628/4885HPGD 2541/4885ALDH1A1 1272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.